APA (7th ed.) Citation

Voysey, M., Weckx, L. Y., Collins, A. M., Hill, H., Lazarus, R., Lawrie, A. M., . . . Webb, S. (2021). Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: An interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. The Lancet (British edition), 397(10269), 99-111. https://doi.org/10.1016/S0140-6736(20)32661-1

Chicago Style (17th ed.) Citation

Voysey, Merryn, et al. "Safety and Efficacy of the ChAdOx1 NCoV-19 Vaccine (AZD1222) Against SARS-CoV-2: An Interim Analysis of Four Randomised Controlled Trials in Brazil, South Africa, and the UK." The Lancet (British Edition) 397, no. 10269 (2021): 99-111. https://doi.org/10.1016/S0140-6736(20)32661-1.

MLA (9th ed.) Citation

Voysey, Merryn, et al. "Safety and Efficacy of the ChAdOx1 NCoV-19 Vaccine (AZD1222) Against SARS-CoV-2: An Interim Analysis of Four Randomised Controlled Trials in Brazil, South Africa, and the UK." The Lancet (British Edition), vol. 397, no. 10269, 2021, pp. 99-111, https://doi.org/10.1016/S0140-6736(20)32661-1.